Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.

Discretionary spending by HHS is the major target of cuts in a preliminary budget from the Trump administration obtained by ...

Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at ...

RISA Labs made the announcement in a statement emailed to The American Journal of Managed Care.

A majority of cases of diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma globally, are ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...

The executive order targets lower drug prices through Medicare reforms, anticompetitive crackdowns, and transparency mandates.

Women living with HIV in Canada were found to have worse wellbeing when they had adversities related to social determinants ...

Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the ...

The proposal aims to align global leaders on pandemic prevention, preparedness, and response to future pandemics.

The electronic health record (EHR)–based symptom inventory identified symptom prevalence and associated comorbidities, but no ...

Progression-free survival improvement and drug costs make zanubrutinib a more cost-effective option in relapsed or refractory ...